865 related articles for article (PubMed ID: 27637015)
1. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
[TBL] [Abstract][Full Text] [Related]
2. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.
González-Rodríguez A; Mayoral R; Agra N; Valdecantos MP; Pardo V; Miquilena-Colina ME; Vargas-Castrillón J; Lo Iacono O; Corazzari M; Fimia GM; Piacentini M; Muntané J; Boscá L; García-Monzón C; Martín-Sanz P; Valverde ÁM
Cell Death Dis; 2014 Apr; 5(4):e1179. PubMed ID: 24743734
[TBL] [Abstract][Full Text] [Related]
3. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease.
Tang M; Jiang Y; Jia H; Patpur BK; Yang B; Li J; Yang C
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):159-168. PubMed ID: 31852298
[TBL] [Abstract][Full Text] [Related]
5. c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning.
Suzuki A; Kakisaka K; Suzuki Y; Wang T; Takikawa Y
World J Gastroenterol; 2016 Jul; 22(28):6509-19. PubMed ID: 27605885
[TBL] [Abstract][Full Text] [Related]
6. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity.
Li S; Dou X; Ning H; Song Q; Wei W; Zhang X; Shen C; Li J; Sun C; Song Z
Hepatology; 2017 Sep; 66(3):936-952. PubMed ID: 28437863
[TBL] [Abstract][Full Text] [Related]
8. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
[No Abstract] [Full Text] [Related]
9. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
[TBL] [Abstract][Full Text] [Related]
10. Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling.
Pyun DH; Kim TJ; Kim MJ; Hong SA; Abd El-Aty AM; Jeong JH; Jung TW
J Cell Physiol; 2021 Jul; 236(7):4902-4912. PubMed ID: 33283879
[TBL] [Abstract][Full Text] [Related]
11. Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice.
Lou J; Li C; Li ZS; Zhang T; Chen ZN; Bian H
Biochem Biophys Res Commun; 2020 Apr; 524(4):1010-1017. PubMed ID: 32063360
[TBL] [Abstract][Full Text] [Related]
12. Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.
Liu X; Li X; Su S; Yuan Y; Liu W; Zhu M; Zheng Q; Zeng X; Fu F; Lu Y; Chen Y
Exp Cell Res; 2023 Aug; 429(2):113655. PubMed ID: 37253404
[TBL] [Abstract][Full Text] [Related]
13. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
[TBL] [Abstract][Full Text] [Related]
15. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-38 alleviates hepatic steatosis through AMPK/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models.
Sun JL; Cho W; Oh H; Abd El-Aty AM; Hong SA; Jeong JH; Jung TW
J Cell Physiol; 2024 Apr; 239(4):e31184. PubMed ID: 38197464
[TBL] [Abstract][Full Text] [Related]
17. Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD.
Ma D; Molusky MM; Song J; Hu CR; Fang F; Rui C; Mathew AV; Pennathur S; Liu F; Cheng JX; Guan JL; Lin JD
Mol Endocrinol; 2013 Oct; 27(10):1643-54. PubMed ID: 23960084
[TBL] [Abstract][Full Text] [Related]
18. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
[TBL] [Abstract][Full Text] [Related]
19. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
20. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
